EP2755973 - SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.09.2016 Database last updated on 31.08.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states SANOFI 54, rue La Boétie 75008 Paris / FR | [2014/30] | Inventor(s) | 01 /
BIALY, Laurent Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | 02 /
LORENZ, Katrin c/o Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | 03 /
WIRTH, Klaus c/o Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | 04 /
STEINMEYER, Klaus c/o Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | 05 /
HESSLER, Gerhard c/o Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | 06 /
PERNERSTORFER, Josef c/o Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | 07 /
BRENDEL, Joachim c/o Sanofi-Aventis Deutschland GmbH Industriepark Hoechst 65926 Frankfurt am Main / DE | [2014/30] | Representative(s) | Venne-Dunker, Sabine Sanofi-Aventis Deutschland GmbH Global Intellectual Property Department Industriepark Höchst Gebäude K 703 65926 Frankfurt am Main / DE | [2014/30] | Application number, filing date | 11757858.3 | 16.09.2011 | [2015/45] | WO2011EP66061 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013037415 | Date: | 21.03.2013 | Language: | EN | [2013/12] | Type: | A1 Application with search report | No.: | EP2755973 | Date: | 23.07.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.03.2013 takes the place of the publication of the European patent application. | [2014/30] | Type: | B1 Patent specification | No.: | EP2755973 | Date: | 04.11.2015 | Language: | EN | [2015/45] | Search report(s) | International search report - published on: | EP | 21.03.2013 | Classification | IPC: | C07D471/04, C07D471/18, A61K31/437, A61K31/439, A61P9/06 | [2014/30] | CPC: |
C07D471/04 (EP,CN,US);
A61P11/00 (EP);
A61P11/16 (EP);
A61P25/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/30] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | SUBSTITUIERTE 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE, IHRE VERWENDUNG ALS MEDIKAMENT UND PHARMAZEUTISCHE PRÄPARATE DAMIT | [2014/30] | English: | SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM | [2014/30] | French: | 4,5,6,7-TÉTRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES SUBSTITUÉES, LEUR UTILISATION EN TANT QUE MÉDICAMENT ET PRÉPARATIONS PHARMACEUTIQUES LES COMPRENANT | [2014/30] | Entry into regional phase | 16.04.2014 | National basic fee paid | 16.04.2014 | Designation fee(s) paid | 16.04.2014 | Examination fee paid | Examination procedure | 16.04.2014 | Examination requested [2014/30] | 12.11.2014 | Amendment by applicant (claims and/or description) | 18.05.2015 | Communication of intention to grant the patent | 21.09.2015 | Fee for grant paid | 21.09.2015 | Fee for publishing/printing paid | 21.09.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.05.2015 | Opposition(s) | 05.08.2016 | No opposition filed within time limit [2016/41] | Fees paid | Renewal fee | 28.02.2014 | Renewal fee patent year 03 | 12.09.2014 | Renewal fee patent year 04 | 11.09.2015 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 04.11.2015 | MK | 04.11.2015 | RS | 04.11.2015 | SM | 04.11.2015 | NO | 04.02.2016 | IS | 04.03.2016 | [2018/46] |
Former [2018/31] | MK | 04.11.2015 | |
RS | 04.11.2015 | ||
SM | 04.11.2015 | ||
NO | 04.02.2016 | ||
IS | 04.03.2016 | ||
Former [2016/38] | RS | 04.11.2015 | |
SM | 04.11.2015 | ||
NO | 04.02.2016 | ||
IS | 04.03.2016 | ||
Former [2016/27] | RS | 04.11.2015 | |
NO | 04.02.2016 | ||
IS | 04.03.2016 | ||
Former [2016/25] | LV | 04.11.2015 | |
RS | 04.11.2015 | ||
NO | 04.02.2016 | ||
IS | 04.03.2016 | ||
Former [2016/23] | RS | 04.11.2015 | |
NO | 04.02.2016 | ||
IS | 04.03.2016 | ||
Former [2016/22] | NO | 04.02.2016 | |
IS | 04.03.2016 | ||
Former [2016/21] | NO | 04.02.2016 | Cited in | International search | [AD]US4500525 (WINTERS GIORGIO [IT], et al) [AD] 1-19 * claim 1 *; | [AD]US2008188477 (BRENDEL JOACHIM [DE], et al) [AD] 1-19 * claims 1, 10-12 * * page 2, paragraph [0018] *; | [E]WO2011115804 (IRONWOOD PHARMACEUTICALS INC [US], et al) [E] 1,5,16,19 * page 31 - page 32; compounds I-38, I-40, I50, I-51, I-52 * * page 33; compounds I-54, I-55, I-56, I-57, I-58, I-63 ** page 61 - page 62, paragraph [0186]; claim 1 *; | [A] - WINTERS G ET AL, "Synthesis, in vitro [3H]prazosin displacement, and in vivo activity of 3-aryl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines, a new class of antihypertensive agents", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19850101), vol. 28, doi:10.1021/JM00145A015, ISSN 0022-2623, pages 934 - 940, XP002256019 [A] 1-19 * page 935; table 1; compounds 22, 25 * DOI: http://dx.doi.org/10.1021/jm00145a015 | by applicant | EP0086422 | WO2005016965 | WO2006136304 | WO2007124849 | - COETZEE W.J. ET AL., "Molecular diversity of K+ channels", ANN. NEW YORK ACAD. SCI., (1999), pages 233 - 285 | - D.A. BAYLISS, P. BARRETT, TRENDS IN PHARMACOLOGICAL SCIENCES, (2008), vol. 29, no. 11, pages 566 - 575 | - BERG AP., TALLEY E.M., MANGER J.P., BAYLISS D.A., "Motoneurons express Heteromeric TWIK-related acid-sensitive K+ (TASK) Channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits", J. NEUROSCIENCE, (2004), pages 6693 - 6702 | - DUPRAT F., LESAGE F., FINK M., REYES R., HEURTEAUX C., LAZDUNSKI M, "TASK, a human background K+ channel to sense external pH variations near physiological pH", EMBO J., (1997), pages 5464 - 5471 | - PATEL A.J., HONORE E., "Properties and modulation of mammalian 2P domain K+ channels", TRENDS NEUROSCI., (2001), doi:doi:10.1016/S0166-2236(00)01810-5, pages 339 - 346, XP004239821 DOI: http://dx.doi.org/10.1016/S0166-2236(00)01810-5 | - JOURNAL OF NEUROSCIENCE, (2005), vol. 25, no. 49, pages 11455 - 11467 | - MEDHURST A.D., RENNIE G., CHAPMAN C.G., MEADOWS H., DUCKWORTH M.D, KELSELL R.E., GLOBER 1.1., PANGALOS M.N., "Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery", MOL. BRAIN RES., (2001), doi:doi:10.1016/S0169-328X(00)00263-1, pages 101 - 114, XP002329245 DOI: http://dx.doi.org/10.1016/S0169-328X(00)00263-1 | - BUCKLER K.J., WILLIAMS B.A., HONORE E., "An oxygen-, acid-and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells", J. PHYSIOL., (2000), pages 135 - 142 | - BAYLISS D.A., TALLEY E.M., SIROIS J.E., LEI Q., "TASK-1 is a highly modulated pH-sensitive 'leak' K+ channel expressed in brainstem respiratory neurons", RESPIRATION PHYSIOLOGY, (2001), pages 159 - 174 | - LAURITZEN , ZANZOURI M., HONORE E., DUPRAT F., EHRENGRUBER M.U., LAZDUNSKI M., PATEL A.J., "K+- dependent cerebellar granule neuron apoptosis - Role of Task leak K+ channels", J. BIOL. CHEM., (2003), pages 32068 - 32076 | - PATEL A.J., LAZDUNSKI M., "The 2P-domain K+ channels: role in apoptosis and tumorigenesis", PFLUGERS ARCH., (2004), doi:doi:10.1007/s00424-004-1255-8, pages 261 - 273, XP002329247 DOI: http://dx.doi.org/10.1007/s00424-004-1255-8 | - BITTNER STEFAN, MEUTH SVEN G, GOBEL KERSTIN, MELZER NICO, HERRMANN ALEXANDER M, SIMON OLE J, WEISHAUPT ANDREAS, BUDDE THOMAS, BAYL, BRAIN : A JOURNAL OF NEUROLOGY, (2009), vol. 132, pages 2501 - 16 | - BASIC RES CARDIOL., (201101), vol. 106, no. 1, pages 75 - 87 | - PUTZKE C, WEMHONER K, SACHSE FB, RINNE S, SCHLICHTHORL G, LI XT, JAE L, ECKHARDT I, WISCHMEYER E, WULF H, CARDIOVASCULAR RESEARCH, (2007), vol. 75, pages 59 - 68 | - OURNAL OF CLINICAL INVEST., (2011), vol. 121, no. 8, pages 2955 - 2968 | - T. J. COLATSKY ET AL., "Potassium channels as targets for antiarrhythmic drug action", DRUG DEV. RES., (1990), vol. 19, pages 129 - 140 | - D. M. RODEN, "Current status of class III antiarrhythmic drug therapy", AM. J. CARDIOL., (1993), vol. 72, pages 44B - 49B | - BASIC. RES. CARDIOL., (2003), vol. 98, pages 137 - 148 | - JACC, (2001), vol. 37, no. 3 | - JOURNAL OF MOLECULAR MEDICINE, (2004), pages 308 - 316 | - EUROPEAN JOURNAL OF PHYSIOLOGY, (2005), vol. 450, pages 201 - 208 | - PATEL A.J., HONORE E., LESAGE F., FINK M., ROMEY G., LAZDUNSKI M, "Inhalational anesthetics activate two-pore-domain background K+ channels", NATURE NEUROSCI., (1999), doi:doi:10.1038/8084, pages 422 - 426, XP002145560 DOI: http://dx.doi.org/10.1038/8084 | - PEUKERT, S., BRENDEL, J., PIRARD, B., BRUEGGEMANN, A., BELOW, P., KLEEMANN, H.-W., HEMMERLE, H., SCHMIDT, W., "Identification, Synthesis, and Activity of Novel Blockers of the Voltage-Gated Potassium Channel Kv1.5.", JOURNAL OF MEDICINAL CHEMISTRY, (2003), vol. 46, no. 4, doi:doi:10.1021/jm0210461, pages 486 - 498, XP002292322 DOI: http://dx.doi.org/10.1021/jm0210461 | - STREIT, A. K., NETTER, M. F., KEMPF, F., WALECKI, M., RINNE, S., BOLLEPALLI, M. K., PREISIG-MUELLER, R., RENIGUNTA, V., DAUT, J.,, "A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore", JOURNAL OF BIOLOGICAL CHEMISTRY, (2011), vol. 286, no. 16, pages 13977 - 13984 | - MAINGRET F., PATEL A.J., LAZDUNSKI M., HONORE E., "The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1", EMBO J., (2001), doi:doi:10.1093/emboj/20.1.47, pages 47 - 54, XP001203548 DOI: http://dx.doi.org/10.1093/emboj/20.1.47 | - COTTEN J.F., KESHAVAPRASAD B, LASTER M.J., EGER E.I., YOST C.S., "The Ventilatory Stimulant Doxapram Inhibits TASK Tandem Pore (K2p) Potassium Channel Function but Does Not Affect Minimum Alveolar Anesthetic Concentration", ANESTH. ANALG., (2006), doi:doi:10.1213/01.ane.0000194289.34345.63, pages 779 - 785, XP009103929 DOI: http://dx.doi.org/10.1213/01.ane.0000194289.34345.63 | - DALISAY, D. S., QUACH, T., NICHOLAS, G. N., MOLINSKI, T. F., ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, (2009), vol. 48, pages 4367 - 4371 | - NOZAKI, S., J. PEPTIDE RES., (1999), vol. 54, page 162 | - KNORR, R. ET AL., TETRAHEDRON LETT., (1989), vol. 30, page 1927 | - ALTERMAN, M., ANDERS, H., JOURNAL OF ORGANIC CHEMISTRY, (2000), vol. 65, no. 23, pages 7984 - 7989 | - KNOBLOCH ET AL., NAUNYN-SCHMIEDBERG'S ARCH. PHARMACOL., (2002), vol. 366, pages 482 - 487 |